Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics ...

New research published in Free Radical Biology and Medicine found that cannabigerol (CBG) may have strong anti-cancer effects ...

Collaboration deploys the High Throughput In Situ Multiomics capabilities of G4X(TM) to support HTAN's Pre-Gastric Cancer program and enable scalable generation of multimodal 3D atlases. SAN DIEGO and ...

Neutrophil infiltration is a hallmark of pulmonary inflammation during respiratory viral infections, yet the origin of these cells has been a subject ...

Researchers are redesigning lipid nanoparticles to do more than shuttle mRNA into cells, with preclinical studies suggesting ...

The field of oncology is currently undergoing a transformation driven by high-throughput proteomics, genomics, and advanced single-cell technologies. These ...

Breast cancer remains one of the most prevalent and life-threatening forms of cancer, impacting millions worldwide. This malignancy's heterogeneity and complexity have long posed significant ...

Background High serum levels of interleukin 6 (IL-6) predict poor prognosis in intrahepatic cholangiocarcinoma (iCCA), a ...

In 2021, a global tuberculosis vaccine research and development roadmap proposed a series of actions to accelerate the development of new, effective, and affordable vaccines that are urgently needed ...

Using single-cell sequencing, researchers found distinct immune profiles in different CNS tumors, highlighting its potential as a prognostic tool.

Researchers identify a gene expression program in the living human brain that tracks with real-time neurotransmission, ...

Caris Life Sciences (NASDAQ:CAI) reported a record fourth quarter in its first full year as a public company, driven by ...